KYTX Stock Analysis: Buy, Sell, or Hold?
KYTX - Kyverna Therapeutics, Inc. Common Stock
$9.49
-1.25 (-11.64%)
▼
5d:
+1.5%
30d:
-0.42%
90d:
+30.72%
BUY
HIGH Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Smart Money Accumulation
KYTX is down 3.3% this week, but smart money is accumulating calls. Top strike: $10 2026-06-18 with 1,618 OI. Call ratio: 92% View Scanner →
Strength: 5.9/10
Get Alerted When KYTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called KYTX this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: KYTX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: KYTX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: KYTX is currently trading at $9.49, which is considered fair relative to its 30-day fair value range of $8.83 to $10.14.
Technical Outlook: Technically, KYTX is in a uptrend. Immediate support is located at $8.72, while resistance sits at $11.15. Short-term momentum is weak, with the stock down 11.6% recently.
Market Sentiment: KYTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $29.60 (+211.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, KYTX is in a uptrend. Immediate support is located at $8.72, while resistance sits at $11.15. Short-term momentum is weak, with the stock down 11.6% recently.
Market Sentiment: KYTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $29.60 (+211.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$8.83 -
$10.14
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
81.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-11.6%)
- BULLISH: Trading 211.9% below Wall St target ($29.60)
Trading Range Analysis
30-Day Trading Range
$8.83 -
$10.14
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$8.72
Resistance Level
$11.15
Current Trend
Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.50
Wall Street Target
$29.60
(+211.9%)
Share & Embed Analysis
Last updated: May 18, 2026 8:33 AM ET
Data refreshes hourly during market hours. Next update: 9:33 AM
Data refreshes hourly during market hours. Next update: 9:33 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KYTX showing a specific setup today?
Insider Activity (6 Months)
2
Buys
1
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Beth C Seidenberg
BUY
133333 shares
2025-12-18
Biopartners Opportuni We…
BUY
133333 shares
2025-12-18
Karen Marie Walker
SELL
23998 shares
2025-12-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 58 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$103 | 55 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$126 | 48 HOLD |
